Overall, AGEs may influence the development of colorectal cancer in type 2 diabetes mellitus patients, supporting the hypothesis that it may be possible to lower the risk of colorectal cancer in the clinic by regulating AGEs through the modulation of blood glucose levels, which will then affect IGF-1 and its receptors [111]. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.